Envoy Medical, Inc. Insider Trading

COCH

⊜ Compare

Last 12 months

Insiders bought 673K on the open market and sold nothing.

Net open-market

+673K

5 buys · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

5 / 0

executives and directors

Last open-market buy

Feb 2026

Feb 12, 2026

Get an email when COCH's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Feb 12	Glen A Taylor Large holder	Bought	18,750,000	$0.40	$7.5M	182%	Form 4
Feb 12	Mona Chetan Patel Director	Bought	312,500	$0.40	125K	1563%	Form 4
Feb 12	Robert Potashnick Interim CFO	Bought	212,500	$0.40	85K	New	Form 4
Feb 12	Susan Kantor Director	Bought	96,150	$0.40	38K	123%	Form 4
Feb 12	Charles Brynelsen Director	Bought	1,000,000	$0.40	400K	2000%	Form 4
Feb 12	Brent T. Lucas Chief Executive Officer	Bought	62,500	$0.40	25K	27%	Form 4
Jun 11, 2025	Mona Chetan Patel Director	Bought	2,500	$1.47	4K	14%	Form 4
Jun 6, 2025	Mona Chetan Patel Director	Bought	10,000	$1.46	15K	133%	Form 4
May 22, 2025 – May 27, 2025	Charles Brynelsen Director	Bought 3 parts	50,000	$1.65 average	82K	New	Form 4
Nov 20, 2024	Mona Chetan Patel Director	Bought	2,500	$2.28	6K	50%	Form 4

Feb 12
Glen A Taylor
Large holder · bought 18,750,000 at $0.40
$7.5M
182% of stake
Feb 12
Mona Chetan Patel
Director · bought 312,500 at $0.40
125K
1563% of stake
Feb 12
Robert Potashnick
Interim CFO · bought 212,500 at $0.40
85K
New position
Feb 12
Susan Kantor
Director · bought 96,150 at $0.40
38K
123% of stake
Feb 12
Charles Brynelsen
Director · bought 1,000,000 at $0.40
400K
2000% of stake
Feb 12
Brent T. Lucas
Chief Executive Officer · bought 62,500 at $0.40
25K
27% of stake
Jun 11, 2025
Mona Chetan Patel
Director · bought 2,500 at $1.47
4K
14% of stake
Jun 6, 2025
Mona Chetan Patel
Director · bought 10,000 at $1.46
15K
133% of stake
May 22, 2025 – May 27, 2025
Charles Brynelsen
Director · bought 50,000 at avg $1.65
82K
New position
Nov 20, 2024
Mona Chetan Patel
Director · bought 2,500 at $2.28
6K
50% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch COCH, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Orthopedic, Prosthetic & Surgical Appliances & Supplies · Pick stocks to compare with COCH

CompareIntrinsic value

NTRBNutriband Inc.

$6.08-3.34%10

FEEDENvue Medical, Inc.

$0.26-25.69%15

NXLNexalin Technology Inc.

$1.56+1.30%10

FOFAFamily Office of America Inc.

$0.78+0.00%16

ENDVEndonovo Therapeutics Inc.

$0.00+0.00%15

POSCPositron Corporation

$1.67-1.76%0

PAVMPAVmed Inc.

$1.66-8.79%25

RDGLVivos Inc.

$0.04-1.64%40

Spot a number that looks wrong? Check it in COCH's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing COCH

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.